RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재

      우리나라와 일본의 병원약사와 관련된 업무에 대한 수가 비교 = Comparative Study on Reimbursement Fees Related to Hospital Pharmacists’Services in Korea and Japan

      한글로보기

      https://www.riss.kr/link?id=A107291270

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Background : Currently, the pharmacists at hospitals in Korea provide professional and diverse pharmaceutical care services. However, the service fee covered by national health insurance (NHI) is limited to the traditional dispensing and managing of medication. In Japan, with a similar health insurance system to Korea, health insurance fees for pharmaceutical care services are rewarded in various types. We aimed to compare the unit price and types of reimbursement activity covered by NHI between Korea and Japan.
      Methods : The 2020 medical fee tables from NHI in Korea and Japan were examined and the unit price and condition were extracted for analysis. The insurance fee of Japan was converted into Korean won using the Purchasing-Power-Parities (PPP) exchange rate. We set various cases for comparison (1-day dispensing for peroral and external use medication and aseptic compounding) in inpatient and outpatient settings.
      Results : In Japan, various fees were awarded for pharmacists’ clinical pharmaceutical care activities besides traditional dispensing and promoting participation in multidisciplinary team activities. Compared to Japan, the level of health insurance fees in Korea was 70–73%, 47–57%, and 19–31% for 1-day dispensing to inpatients, outpatients, and discharge patients, respectively.
      For aseptic compounding for three-drug chemotherapy regimens and parenteral nutrition, the levels were estimated at 103–116% and 122%, respectively.
      Conclusion : The hospital pharmacists’ services fees in Korea were lower than those in Japan for traditional dispensing activities. There were more types of health insurance fees in Japan, and the terms and conditions that must be met to be awarded were very specific.
      번역하기

      Background : Currently, the pharmacists at hospitals in Korea provide professional and diverse pharmaceutical care services. However, the service fee covered by national health insurance (NHI) is limited to the traditional dispensing and managing of m...

      Background : Currently, the pharmacists at hospitals in Korea provide professional and diverse pharmaceutical care services. However, the service fee covered by national health insurance (NHI) is limited to the traditional dispensing and managing of medication. In Japan, with a similar health insurance system to Korea, health insurance fees for pharmaceutical care services are rewarded in various types. We aimed to compare the unit price and types of reimbursement activity covered by NHI between Korea and Japan.
      Methods : The 2020 medical fee tables from NHI in Korea and Japan were examined and the unit price and condition were extracted for analysis. The insurance fee of Japan was converted into Korean won using the Purchasing-Power-Parities (PPP) exchange rate. We set various cases for comparison (1-day dispensing for peroral and external use medication and aseptic compounding) in inpatient and outpatient settings.
      Results : In Japan, various fees were awarded for pharmacists’ clinical pharmaceutical care activities besides traditional dispensing and promoting participation in multidisciplinary team activities. Compared to Japan, the level of health insurance fees in Korea was 70–73%, 47–57%, and 19–31% for 1-day dispensing to inpatients, outpatients, and discharge patients, respectively.
      For aseptic compounding for three-drug chemotherapy regimens and parenteral nutrition, the levels were estimated at 103–116% and 122%, respectively.
      Conclusion : The hospital pharmacists’ services fees in Korea were lower than those in Japan for traditional dispensing activities. There were more types of health insurance fees in Japan, and the terms and conditions that must be met to be awarded were very specific.

      더보기

      참고문헌 (Reference)

      1 도영경, "환자중심성 평가모형 개발 연구 개발 연구" 건강보험심사평가원·서울대학교 산학협력단 2015

      2 "하나은행 환율/외화예금 금리 조회: 2019년 연평균"

      3 이은숙, "의료기관 약제서비스 강화를 통한 의약품 안전사용 확보 방안 연구보고서" 보건복지부·한국병원약사회 2017

      4 윤정현, "외래환자 대상 당뇨병 약료서비스 모델 개발" 한국임상약학회 27 (27): 1-8, 2017

      5 한국병원약사회-보험위원회, "약제수가 신설 및조정"

      6 송영천, "수가체계 내에서의 병원약제 업무의 위치및 가치평가" 31 (31): 1054-1066, 2014

      7 남상요, "김영재 et al. 일본의 의료보험제도 및 진료비지불체계에 관한 연구" 대한의사협회 의료정책연구소 1-346, 2010

      8 이소영, "국내 병원약사의 중재활동과 성과에 대한 체계적 문헌고찰" 한국임상약학회 29 (29): 193-201, 2019

      9 한상완, "구매력평가 환율로 본 엔화 가치" 현대경제연구원 13 (13): 1-12, 2013

      10 "診療報酬点数表Web"

      1 도영경, "환자중심성 평가모형 개발 연구 개발 연구" 건강보험심사평가원·서울대학교 산학협력단 2015

      2 "하나은행 환율/외화예금 금리 조회: 2019년 연평균"

      3 이은숙, "의료기관 약제서비스 강화를 통한 의약품 안전사용 확보 방안 연구보고서" 보건복지부·한국병원약사회 2017

      4 윤정현, "외래환자 대상 당뇨병 약료서비스 모델 개발" 한국임상약학회 27 (27): 1-8, 2017

      5 한국병원약사회-보험위원회, "약제수가 신설 및조정"

      6 송영천, "수가체계 내에서의 병원약제 업무의 위치및 가치평가" 31 (31): 1054-1066, 2014

      7 남상요, "김영재 et al. 일본의 의료보험제도 및 진료비지불체계에 관한 연구" 대한의사협회 의료정책연구소 1-346, 2010

      8 이소영, "국내 병원약사의 중재활동과 성과에 대한 체계적 문헌고찰" 한국임상약학회 29 (29): 193-201, 2019

      9 한상완, "구매력평가 환율로 본 엔화 가치" 현대경제연구원 13 (13): 1-12, 2013

      10 "診療報酬点数表Web"

      11 ⽇医⼯医業経営研究所, "病院薬剤師が係わる主な医科診療報酬"

      12 厚生労働省, "令和2年度診療報酬"

      13 今日の臨床サポ一ト, "令和2年度診療報酬"

      14 "The World Bank: GDP per capita (current US$)"

      15 OECD.Stat, "Purchasing Power Parities for GDP and related indicators"

      16 건강보험심사평가원, "2020년 3월판 건강보험요양급여비용 최종"

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2028 평가예정 재인증평가 신청대상 (재인증)
      2022-01-01 평가 등재학술지 유지 (재인증) KCI등재
      2019-01-01 평가 등재학술지 유지 (계속평가) KCI등재
      2016-01-01 평가 등재학술지 선정 (계속평가) KCI등재
      2015-01-01 평가 등재후보학술지 유지 (계속평가) KCI등재후보
      2013-01-01 평가 등재후보학술지 유지 (기타) KCI등재후보
      2012-01-01 평가 등재후보학술지 유지 (기타) KCI등재후보
      2010-07-02 학회명변경 한글명 : 병원약사회 -> 한국병원약사회
      영문명 : 미등록 -> The Korean Society of Health-System Pharmacists
      KCI등재후보
      2010-01-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 0.04 0.04 0.04
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.05 0.05 0.27 0
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼